Rosuvastatin antilipemic agent Rosuvastatin kurapa dyslipidemia
Tsanangudzo Yakadzama
Rosuvastatin inhibits enzyme hydroxymethylglutaryl-CoA reductase muchiropa, iyo inoderedza cholesterol synthesis uye inoderedza serum cholesterol uye triglyceride mazinga. Uyezve, Rosuvastatin inowedzera kutora kwechiropa uye kuparara kweyakaderera-density lipoprotein cholesterol (LDL-C), uyewo ichikwidza mazinga e-high-density lipoprotein cholesterol (HDL-C). Pamusoro peiyo lipid-kudzikisa mhedzisiro, Rosuvastatin yakaratidza kuve ine anti-atherosclerotic, anti-inflammatory, antioxidant, plaque stabilizing, uye yakagadziridzwa endothelial function properties.
Rosuvastatin inogadzirwa kuburikidza nekuvirisa kweAspergillus terreus kana kuburikidza nemakemikari synthesis. Kana yangopinzwa, inogadziriswa zvakanyanya muchiropa uye inoshandurwa kuita akasiyana metabolites, kusanganisira inoshanda metabolites inodzivirira HMG-CoA reductase. Mushonga wacho nemametabolites ayo anonyanya kubudiswa mutsvina, ane chidimbu chiduku chinobudiswa muweti.